#012 Dr. Ronald Krauss on LDL Cholesterol, Particle Size, Heart Disease & Atherogenic Dyslipidemia
Dr. Ronald Krauss, a pioneering scientist in cardiovascular research, discusses how his work transformed understanding of cholesterol, LDL particle sizes, and the impact of diet (saturated fat vs. refined carbs) on heart disease risk. He also covers statins and the importance of personalized risk assessment.
Deep Dive Analysis
10 Topic Outline
Introduction to Dr. Krauss and Lipoprotein Research
Overview of Lipoproteins: HDL, LDL, and VLDL
Understanding Small, Dense LDL Particles and Heart Disease Risk
HDL's Role in Cholesterol Removal and Therapeutic Limitations
Inflammation, VLDL Production, and Lipoprotein Host Defense
Dietary Cholesterol's Minimal Impact on Blood Cholesterol
Saturated Fats vs. Carbohydrates and LDL Particle Effects
Statins: Mechanisms, Efficacy, and Adverse Effects
The Value and Underutilization of LDL Particle Size Measurement
Refining Heart Disease Risk Assessment and Treatment Decisions
7 Key Concepts
LDL Cholesterol vs. LDL Particles
LDL cholesterol measures the total cholesterol carried within all LDL particles, but these particles vary in size and density. Different LDL particle forms have distinct metabolic and pathological properties, with smaller, denser particles being more damaging than larger, buoyant ones.
Small, Dense LDL Particles
These particles carry less cholesterol but have a greater tendency to enter and stick to artery walls, are more easily oxidized, and are less efficiently removed from the blood by the liver's LDL receptors. Their prolonged circulation and damaging properties contribute significantly to heart disease risk.
Atherogenic Dyslipidemia
This is a collection of interrelated metabolic traits strongly associated with increased heart disease risk. It includes high levels of small, dense LDL particles, low levels of HDL cholesterol, and elevated levels of triglyceride-rich lipoproteins and their remnants.
VLDL (Very Low Density Lipoproteins)
VLDL particles originate in the liver, primarily transporting triglycerides, with cholesterol as a 'passenger.' As triglycerides are broken down and used by the body, VLDL particles shrink, eventually forming smaller, denser LDL particles.
Host Defense Role of VLDL
VLDL secretion by the liver may serve an important role in host defense, acting as a rapid response system to infection. These particles carry pro-inflammatory and pro-thrombotic proteins and can bind and sequester toxins like lipopolysaccharides (LPS), helping to fight off infectious agents.
LDL Receptor Activity
LDL receptors, particularly in the liver, are crucial for removing LDL particles from the blood. Statins primarily lower LDL by increasing the activity of these receptors, leading to more efficient clearance of LDL, though their effect is blunted for smaller, denser LDL particles.
Relative vs. Absolute Risk
Relative risk describes how much a particular factor increases the likelihood of an event (e.g., two or three-fold increase). Absolute risk refers to the overall chance of that event occurring. It's important to consider absolute risk when making treatment decisions, as a large relative increase on a very small absolute risk may still result in a low overall risk.
10 Questions Answered
The traditional view of 'good' HDL and 'bad' LDL cholesterol is an oversimplification because LDL actually consists of various particle sizes and densities. While LDL cholesterol is a general risk indicator, smaller, denser LDL particles are more damaging than larger, buoyant ones, which carry more cholesterol but have fewer pathological features.
Small, dense LDL particles are more dangerous because they have a greater tendency to bind to artery tissue, stick within the artery wall, are more easily oxidized, and are less efficiently removed from the blood by the liver's LDL receptors, leading to prolonged circulation and increased opportunity for damage.
While low HDL cholesterol is associated with increased heart disease risk, efforts to reduce risk by treatments specifically aimed at raising HDL cholesterol have largely failed. This suggests that HDL may be more of a marker for other metabolic issues (like atherogenic dyslipidemia) rather than a direct causal factor for heart disease in the same way LDL is.
Inflammation, often triggered by foreign agents or plaques, stimulates the liver to rapidly produce and secrete VLDL particles. This is hypothesized to be an ancient host defense mechanism, as VLDL carries pro-inflammatory and pro-thrombotic proteins and can bind to and sequester toxins like lipopolysaccharides (LPS), aiding in their removal.
The effect of dietary cholesterol on blood cholesterol levels is surprisingly small, almost unmeasurable for most people. The body regulates its own cholesterol production and absorption, meaning that consuming foods high in cholesterol, like eggs, does not necessarily lead to a significant increase in blood cholesterol for the general population.
Studies have shown that saturated fats tend to increase larger, more buoyant LDL particles, which are considered less dangerous, leading to questions about their direct role in heart disease risk. Conversely, high carbohydrate diets, especially those rich in simple sugars like fructose, promote the production of VLDL particles from the liver, which then lead to the formation of more small, dense LDL particles, increasing atherogenic dyslipidemia.
Statins primarily lower LDL by increasing the activity of LDL receptors in the liver, which more efficiently remove LDL particles from the blood. However, statins have a blunted effect on smaller, denser LDL particles, which are less efficiently cleared by these receptors, meaning statins could be even more effective if they targeted these particles more directly.
Significant adverse effects of statins include muscle metabolism issues (ranging from rare severe damage to more widespread, subtle changes in muscle function) and a surprising risk of developing type 2 diabetes, affecting about 11-12% of users, and potentially 30-40% of otherwise healthy women. Given these risks, particularly for primary prevention in healthy individuals, there's a concern that statins may be overprescribed without sufficient consideration of individual risk-benefit profiles.
The advanced LDL particle size measurement, despite its value, faces slow adoption due to confusion from multiple competing methodologies, a lack of full conviction among some medical professionals about the differential impact of particle sizes, and historical issues with standardization and cost. While these barriers are decreasing, widespread integration is still pending.
While standard lipid tests are generally good for population screening, LDL particle measurements are most beneficial for individuals with 'garden variety' or borderline LDL cholesterol levels (e.g., around 115-120 mg/dL). In this range, particle analysis can significantly refine risk assessment and help target appropriate treatments, especially when considering intervention.
19 Actionable Insights
1. Focus on Dietary Patterns
When considering diet and heart disease risk, focus on overall dietary patterns and the context in which nutrients are consumed, rather than individual nutrients in isolation.
2. Limit High Carbohydrate Diets
Limit high carbohydrate diets, as they can promote the production of VLDL particles that lead to small, dense LDL, high triglycerides, and lower HDL, contributing to atherogenic dyslipidemia.
3. Reduce Simple Sugars, Fructose
Reduce consumption of simple sugars and fructose, especially added sugars, as they are considered chief culprits in promoting atherogenic dyslipidemia.
4. Prefer Fructose in Whole Fruits
Consume fructose in the context of whole fruits, as the fiber and overall packaging buffer its metabolic effects, making it much less problematic than concentrated added sugars.
5. Avoid Processed Starches
Avoid processed starches because they add calories without providing the nutrients found in fiber-rich whole grains.
6. Recognize Added Sugars Problem
Recognize that added sugars are a significant health problem, a point of consensus even among those who previously focused solely on fat as a culprit.
7. Prioritize Lifestyle Interventions
Work on controllable lifestyle factors, including diet and exercise, to reduce heart disease risk and promote overall health, especially for residual risk not addressed by other means.
8. Physicians Monitor LDL Particles
Physicians should monitor LDL particle measurements, especially smaller particles, as the primary target for drug treatment efficacy, rather than solely relying on LDL cholesterol levels.
9. Use Particle Analysis for Treatment Decisions
Use LDL particle analysis in clinical practice, particularly when making treatment decisions for patients considering interventions, as it provides crucial information for targeting treatments like statins or diet.
10. Use Particle Analysis for Borderline Risk
For individuals with borderline LDL cholesterol levels (e.g., 115-120 mg/dL) or those on the cusp of treatment decisions, use LDL particle analysis to refine risk assessment and target appropriate interventions.
11. Treat Very High LDL with Statins
If LDL cholesterol is 190 mg/dL or greater, statin therapy is almost always indicated due to sufficiently high lifelong heart disease risk, often linked to genetic abnormalities, making particle measurement less critical for the initial treatment decision.
12. Consider Statins for High Risk
If you remain at high risk for heart disease, consider statin prescriptions as they have a statistically real effect on reducing risk, though lifestyle changes are also important.
13. Use Precision Medicine for Statins
Advocate for using precision medicine, genomic medicine, and refined laboratory tools like particle measurements to better identify individuals most likely to benefit from statin use and minimize adverse effects like type 2 diabetes.
14. Differentiate Risk Prediction, Treatment
Do not confuse the ability to predict risk using standard measurements with what biological factors should be targeted for treatment, as they are not always the same.
15. Assess Absolute Heart Disease Risk
When evaluating heart disease risk and potential treatment benefits, consider absolute risk rather than just relative risk, as a significant relative increase on a very low baseline risk still results in a small absolute risk.
16. Broaden Diet’s Health Impact
Understand that dietary regulators of heart disease risk extend beyond just blood cholesterol, implying a need to consider other factors.
17. Support FoundMyFitness Podcast
Support the FoundMyFitness podcast by checking out its crowdfunding campaign on foundmyfitness.com or Patreon.com/foundmyfitness.
18. Download FoundMyFitness App
Download the FoundMyFitness mobile app (Android or iPhone) by searching ‘foundmyfitness’ on Google Play or the App Store to receive updates and news in science, health, fitness, nutrition, neuroscience, and aging.
19. Connect with FoundMyFitness Online
Stay updated and engage by following FoundMyFitness on Twitter, Facebook, and Instagram (@FoundMyFitness), as tweets are often read and replied to.
8 Key Quotes
When we measure LDL cholesterol, it's really the summation of cholesterol in a whole series of LDL particles that range from very small and compact or dense LDL to large and more...people use the word fluffy, which is a term I'm not particularly fond of, but it's buoyant.
Dr. Ronald Krauss
The particles that are smaller and more dense do bring cholesterol into the arteries, but they have other properties that make them more damaging to the arteries... versus the larger LDL that even though they have more cholesterol, do not have the same pathologic features.
Dr. Ronald Krauss
The fundamental role of cholesterol is one that promotes health. Where we get into trouble is when it exceeds the ability of cells to take cholesterol out of the blood, particularly through the liver, and it builds up in the blood and gets into the arteries is where it becomes pathologic.
Dr. Ronald Krauss
Cholesterol, in a sense, is a passenger on a train that is mainly delivering triglyceride.
Dr. Ronald Krauss
Trying to raise HDL cholesterol is not necessarily guaranteed to reduce heart disease risk the same way low LDL is.
Dr. Ronald Krauss
For the most part, the effect [of dietary cholesterol on blood cholesterol] was so small that it was almost unmeasurable.
Dr. Ronald Krauss
Statins have not been studied, just huge segments of the population, men, women, different ethnic groups, different lipid levels, and they seem to have a similar benefit across that population. But it's not 100%, and it's not even 50% for the most part. So there is a residual risk on statins that we still have to solve how we best approach that.
Dr. Ronald Krauss
Don't confuse the ability to predict risk with what you should be treating, because those are not always the same.
Dr. Ronald Krauss